Brixey & Meyer Capital

Michael Shane is the named Founding Investment Committee Member and the figure publicly associated with deal origination and stewardship since the firm's predecessor syndicate launched in 2007. The firm has not published bios for additional investment committee members or disclosed a separate CIO, so the governance structure beyond Shane remains private.

The firm grew out of a 2007-vintage syndicate that Michael Shane used to connect high-net-worth individuals with direct investment opportunities. That intermediary model — pairing local private capital with founder- and family-owned businesses — remains the firm's visible origination posture, with all known targets located in the US Midwest and Southeast corridor.

No negative sector exclusions have been published. Observed activity concentrates on industrial manufacturing, healthcare services, distribution, and physical security/access-control businesses — all traditional lower middle market service and light-industrial verticals without exposure to software, biotech, or financial services.

Publicly available information does not document co-investment activity alongside unaffiliated GPs. The firm's syndicate origin and fund structure suggest deal-by-deal capital formation from its own LP base rather than partnering with outside sponsors, though no formal policy has been stated.